Avid Bioservices Inc (CDMO)

[jakedogman1]

the real issue for me is revenue expansion via the vacant space. as soon as the when and how it will be paid are the next big questions. Oncologie just got funded by a VC firm. They have updated their website and note on their recent pr they plan on partnering and licensing the tech. The VC firm has some strong biotech exec's and no way ES and crew have anything to do with Oncologie. And note the UTSW trial with Keytruda is cosponsored by Merck. So CDMO should be getting the $8 mil and maybe some milestones and a bavi manuf contract. They filled the east coast business dev position and you don't hire or accept a job without capacity to sell. Lias said the exp space buildout will cost $30 mil.... I would not be surprised to see a small cap raise during the russell madness and demand for shares with some announcements on contracts. If not during Russell, then by the July CC. Expansion is the value driver and CDMO could help fund with their success.